PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CMAX vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CMAX and SPY is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CMAX vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CareMax, Inc. (CMAX) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-100.00%
7.41%
CMAX
SPY

Key characteristics

Sharpe Ratio

CMAX:

-0.25

SPY:

1.75

Sortino Ratio

CMAX:

-0.70

SPY:

2.36

Omega Ratio

CMAX:

0.90

SPY:

1.32

Calmar Ratio

CMAX:

-1.00

SPY:

2.66

Martin Ratio

CMAX:

-1.20

SPY:

11.01

Ulcer Index

CMAX:

83.48%

SPY:

2.03%

Daily Std Dev

CMAX:

405.60%

SPY:

12.77%

Max Drawdown

CMAX:

-100.00%

SPY:

-55.19%

Current Drawdown

CMAX:

-100.00%

SPY:

-2.12%

Returns By Period

In the year-to-date period, CMAX achieves a -99.01% return, which is significantly lower than SPY's 2.36% return.


CMAX

YTD

-99.01%

1M

0.00%

6M

-100.00%

1Y

-100.00%

5Y*

N/A

10Y*

N/A

SPY

YTD

2.36%

1M

-1.07%

6M

7.41%

1Y

19.73%

5Y*

14.21%

10Y*

12.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CMAX vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CMAX
The Risk-Adjusted Performance Rank of CMAX is 1616
Overall Rank
The Sharpe Ratio Rank of CMAX is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of CMAX is 1616
Sortino Ratio Rank
The Omega Ratio Rank of CMAX is 1515
Omega Ratio Rank
The Calmar Ratio Rank of CMAX is 00
Calmar Ratio Rank
The Martin Ratio Rank of CMAX is 1515
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7676
Overall Rank
The Sharpe Ratio Rank of SPY is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7272
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7575
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7878
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CMAX vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CareMax, Inc. (CMAX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CMAX, currently valued at -0.25, compared to the broader market-2.000.002.00-0.251.75
The chart of Sortino ratio for CMAX, currently valued at -0.70, compared to the broader market-4.00-2.000.002.004.006.00-0.702.36
The chart of Omega ratio for CMAX, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.32
The chart of Calmar ratio for CMAX, currently valued at -1.00, compared to the broader market0.002.004.006.00-1.002.66
The chart of Martin ratio for CMAX, currently valued at -1.20, compared to the broader market-10.000.0010.0020.0030.00-1.2011.01
CMAX
SPY

The current CMAX Sharpe Ratio is -0.25, which is lower than the SPY Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of CMAX and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.25
1.75
CMAX
SPY

Dividends

CMAX vs. SPY - Dividend Comparison

CMAX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.18%.


TTM20242023202220212020201920182017201620152014
CMAX
CareMax, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.18%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

CMAX vs. SPY - Drawdown Comparison

The maximum CMAX drawdown since its inception was -100.00%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for CMAX and SPY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-100.00%
-2.12%
CMAX
SPY

Volatility

CMAX vs. SPY - Volatility Comparison

The current volatility for CareMax, Inc. (CMAX) is 0.00%, while SPDR S&P 500 ETF (SPY) has a volatility of 3.38%. This indicates that CMAX experiences smaller price fluctuations and is considered to be less risky than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%100.00%200.00%300.00%400.00%SeptemberOctoberNovemberDecember2025February0
3.38%
CMAX
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab